- Telehealth Visits
Angel Nip, MB CHB
She | Her | HersPediatric Endocrinology- Telehealth Visits
Angel Nip, MB CHB
She | Her | HersPediatric Endocrinology- Telehealth Visits
On this page
About me
Dr. Angel Nip is a pediatric endocrinologist who cares for children and adolescents with diabetes and other hormonal conditions, including thyroid disorders, growth disorders, puberty disorders and polycystic ovarian syndrome (PCOS). She has a special interest in treating patients with Turner syndrome.
In her research, Nip looks at the psychological and social effects of diabetes on young children and adolescents, which can include depression and disordered eating. She is also involved in initiatives to improve the quality of patient care.
Nip earned her medical degree at the Chinese University of Hong Kong. She completed a residency in pediatrics at UCSF and a fellowship in pediatric endocrinology at Seattle Children's Hospital, an affiliate of the University of Washington School of Medicine.
Education
Board Certification
- Pediatric Endocrinology, American Board of Pediatrics
- General Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Endocrinology, University of Washington School of Medicine
- Pediatrics, Prince of Wales Hospital Li Ka Shing
Residency
- Pediatrics, Univ of CA San Francisco (GME)
- Pediatrics, Prince of Wales Hospital Li Ka Shing
School
- MB CHB, Chinese University of Hong Kong
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.